CLDN18.2 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells

Cellular Signalling 2026

View at publisher
Authors: Feng Xu, Haidi Xu, Yongkuan Guo, Ran Zhang, H. Chen
DOI: 10.1016/j.cellsig.2026.112458
Cited by: 0
References: 39

Fields of Study & Subjects

CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Journal / source
Cellular Signalling
Volume
143
Pages
112458–112458
Publication date
3 March 2026
Language
EN